SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has expanded the clinical footprint of its SSi Mantra surgical robotic system with the launch of a robotic cardiac surgery program at HCG Hospital, Mithakhali, in Ahmedabad, India. The program began with a robotic cardiac surgery LIMA take-down performed using the SSi Mantra 3.0 system. The procedure was led by Dr. Brajmohan Singh and proctored by Dr. Lalit Malik, with support from the SS Innovations team.
This development matters because it demonstrates the growing adoption of robotic-assisted cardiac surgery in India, a country with a high burden of cardiovascular disease. By enabling minimally invasive procedures, the SSi Mantra system can potentially reduce patient recovery times, lower complication rates, and improve surgical outcomes. The launch at HCG Hospital, a prominent cancer and cardiac care center, signals increasing trust in indigenous robotic technology for complex heart surgeries.
The company reported 238 SSi Mantra systems installed as of September 8, up 42% from the end of 2025. The system is now installed across 12 countries, with recent expansion into Colombia, Sri Lanka, and the Philippines. This rapid international growth underscores the system's competitiveness in the global surgical robotics market, which has traditionally been dominated by a few large players.
SS Innovations is pursuing U.S. FDA review and European Union CE marking as it seeks to expand SSi Mantra into additional international markets. Regulatory approvals in these regions would significantly enhance the company's credibility and open access to high-value markets. The company's progress in these regulatory pathways will be closely watched by investors and industry analysts.
In a LinkedIn post, the company congratulated Dr. Brajmohan Sinh, Dr. Lalit Malik, and the entire team at HCG Hospital for this achievement, and thanked them for their trust and commitment in advancing robotic cardiac surgery in the region. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII.
InvestorWire (InvestorWire) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement to ensure maximum impact, social media distribution via IBN to millions of social media followers, and a full array of tailored corporate communications solutions.
For more information, please visit https://www.InvestorWire.com. Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer.
